Evidence mapPaperPMID 41472225Full record

ReviewViruses2025

Acute Respiratory Infections (ARIs): Current Etiological Perspectives and Advances in Viral Metagenomics-A Review.

Murilo Marconi Dos Santos, Tiago Souza Salles, Gabriel Montenegro de Campos, Isabela Carvalho Brcko, Alex Ranieri Jerônimo Lima, Sandra Coccuzzo Sampaio, Maria Carolina Elias, Marta Giovanetti, Svetoslav Nanev Slavov

Abstract readReview
In one paragraph

Review in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Murilo Marconi Dos SantosCenter for Viral Surveillance and Serological Assessment (CeVIVAs), Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0001-6929-9475
Tiago Souza SallesCenter for Viral Surveillance and Serological Assessment (CeVIVAs), Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0002-5822-1426
Gabriel Montenegro de CamposCenter for Viral Surveillance and Serological Assessment (CeVIVAs), Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0001-5181-415X
Isabela Carvalho BrckoCenter for Viral Surveillance and Serological Assessment (CeVIVAs), Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0002-6036-520X
Alex Ranieri Jerônimo LimaCenter for Viral Surveillance and Serological Assessment (CeVIVAs), Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0002-5283-7502
Sandra Coccuzzo SampaioCenter for Viral Surveillance and Serological Assessment (CeVIVAs), Butantan Institute, São Paulo 05503-900, Brazil.
Maria Carolina EliasCenter for Viral Surveillance and Serological Assessment (CeVIVAs), Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0002-0501-8280
Marta GiovanettiDepartment of Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.ORCID 0000-0002-5849-7326
Svetoslav Nanev SlavovCenter for Viral Surveillance and Serological Assessment (CeVIVAs), Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0003-0805-6140

Funding

CNPq 403075/2023-8, 305111/2022-1FAPESP 17/23205-8, 23/12155-0, 21/11944-6, 23/07688-0
6 · The paper itself

Abstract

Acute respiratory infections (ARIs) remain a leading cause of global morbidity and mortality, disproportionately affecting vulnerable populations such as children, the elderly, and immunocompromised individuals. Despite the availability of traditional diagnostic tools, including viral culture and highly elaborated PCR respiratory panels, many cases of ARI remain without an identified etiological agent. This is due to the vast diversity of viral agents that can be involved in cases of ARI, which represents a major limitation of the targeted diagnosis. In this context, viral metagenomics has emerged as a powerful, unbiased approach for detecting both known and novel pathogens directly from clinical samples. This review highlights the application of metagenomic next-generation sequencing for the investigation of etiological causes of ARIs, emphasizing its relevance in complex cases-particularly among immunocompromised patients-where standard methods might fail. We highlight the main viruses involved in respiratory infections, the strengths and limitations of metagenomic next-generation sequencing approaches, their role in genomic surveillance of respiratory viruses, and their potential to build public health responses to potentially emerging respiratory threats. Ultimately, integrating viral metagenomics into clinical and surveillance frameworks could enhance the early detection and control of respiratory viral diseases worldwide.

Indexed as

MetagenomicsRespiratory Tract InfectionsVirus DiseasesVirusesAcute DiseaseGenome, ViralHigh-Throughput Nucleotide SequencingHumansacute respiratory infectionsdiagnosisrespiratory virusesviral metagenomics

Identifiers

PMID41472225
PMCPMC12737513

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.